The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease

Li-Li Zhang1, Rui-Jie Tang2, Yue-Jin Yang1

  • 1State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Ferroptosis, a novel cell death pathway, significantly impacts cardiovascular diseases (CVDs). Understanding its mechanisms offers new avenues for cardio-protection and improved heart disease treatment.

Area of Science:

  • Biomedical science
  • Cardiology
  • Cellular biology

Background:

  • Cardiovascular diseases (CVDs) are a major health concern, with cellular loss accelerating disease progression.
  • Necrosis, apoptosis, and necroptosis are known contributors to cardiac dysfunction.
  • Ferroptosis, a newly identified iron-dependent cell death, is emerging as a key factor in cardiovascular disorders.

Purpose of the Study:

  • To systematically summarize the molecular mechanisms regulating ferroptosis in cardiovascular diseases.
  • To elucidate the role of ferroptosis in the development and progression of heart conditions.
  • To identify potential therapeutic targets for cardio-protection based on ferroptosis regulation.

Main Methods:

  • Literature review and systematic analysis of molecular mechanisms.
  • Categorization of regulatory networks involved in ferroptosis.
  • Identification of potential therapeutic strategies targeting ferroptosis pathways.

Main Results:

  • Ferroptosis is a critical regulator of cardiovascular disorders, distinct from other programmed cell death types.
  • Understanding ferroptosis mechanisms is crucial for developing effective cardio-protective strategies.
  • The study outlines a regulatory network of ferroptosis relevant to diverse cardiovascular conditions.

Conclusions:

  • Ferroptosis plays a significant role in the pathophysiology of cardiovascular diseases.
  • Targeting ferroptosis pathways presents a promising therapeutic strategy for managing heart conditions.
  • Further research into ferroptosis regulation can lead to improved patient prognosis for CVDs.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
784
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.0K